Roadmap to #1

Individual pages for every key term in cannabis science — cannabinoids, receptors, pharmacology, clinical trial terminology, regulatory terms, and more. Each with DefinedTerm schema markup for Google rich results.

Dedicated pages for chronic pain, anxiety, epilepsy, PTSD, multiple sclerosis, cancer, sleep disorders, and IBD — each with MedicalCondition schema, evidence summaries, relevant studies, and compound cross-links.

Research explainers, clinical guides, and policy analysis — 2,000–4,000 words each. Topics: ECS deep dive, CBD vs THC clinical differences, drug interactions guide, adolescent brain, dosing guide, opioid crisis, CBG research, Schedule I barriers, terpene science, how to read cannabis research.

Double the Q&A database to 100+ entries covering every major topic area: pharmacology, neuroscience, clinical applications, safety, pediatric use, sports medicine, reproductive health, addiction, policy, and patient education.

Add 10 more leading researchers: Nora Volkow (NIDA), Margaret Haney (Columbia), Igor Grant (UCSD), Ryan Vandrey (Johns Hopkins), Zach Walsh (UBC), and others. Full Person schema with ORCID, PubMed, Google Scholar.

Expand the research library with 10 more landmark studies — Epidiolex Phase 3 trials, MAPS PTSD studies, Israeli pain studies, Australian medicinal cannabis registry data, and recent 2024–2025 meta-analyses.

CBDV (cannabidivarin), THCP (tetrahydrocannabiphorol), CBN (expanded), Delta-8 THC (regulatory context), and HHC (hexahydrocannabinol). Each with Drug schema, mechanism of action, and clinical evidence summary.

A standalone methodology guide explaining RCT design, blinding challenges in cannabis research, placebo construction, self-report bias, Schedule I research barriers, and how to interpret effect sizes. Aimed at patients and clinicians.

Interactive map and table showing medical/recreational status, possession limits, home cultivation rules, dispensary access, and employer drug testing protections for all 50 US states + DC + territories.

Anonymized, clinician-reviewed case studies showing real-world cannabis use for specific conditions — dosing protocols, outcomes, adverse effects, and lessons learned. Distinct from clinical trial data.

Select a cannabinoid (CBD, THC, CBG) and a drug class or specific medication — get a structured interaction summary: mechanism (CYP450 inhibition, etc.), severity rating, clinical evidence level, and monitoring recommendations.

Condition-specific dosing guidance: select condition, route of administration, prior cannabis experience, and body weight — receive a starting dose range with titration schedule, based on published clinical protocols.

Side-by-side comparison of any two cannabinoids across: mechanism of action, receptor affinity, bioavailability, evidence strength by condition, drug interactions, and legal status. Shareable comparison URLs.

Searchable, filterable interface over the trials database — filter by condition, phase, status (recruiting/completed), cannabinoid, country, and sponsor. Each trial links to ClinicalTrials.gov.

For each condition, display a visual evidence pyramid showing number of RCTs, meta-analyses, observational studies, and case reports — with color-coded confidence ratings (strong/moderate/limited/insufficient).

Downloadable, print-ready one-page guides for each condition — designed for patients to bring to their doctor. Covers: what the research shows, questions to ask, dosing ranges, and red flags.

Visual graph showing how the 20+ researchers on the site cite each other — built from publication data. Reveals research clusters, key connectors, and emerging areas.

Generate unique Open Graph images for every major page — topic hubs, compound pages, conditions, and articles — using a consistent template with the page title, category, and site branding. Currently all pages share one generic OG image.

Compound pages currently breadcrumb to /research instead of /compounds. Topic pages breadcrumb to /research instead of /topics. Fix parent links in BreadcrumbList JSON-LD and visible nav on all 23 affected pages.

CBC, THCV, CBDA, THCA, and Anandamide pages are missing the relatedTopics cross-link section that the original 5 compound pages have. Add topic cross-links to complete the internal link graph.

Add /conditions, /insights, and /glossary to the main navigation. Add /conditions and /insights to the footer. Currently these major sections are only discoverable via the homepage or direct URL.

Audit and optimize LCP, CLS, and INP across all pages. Priorities: font loading (preconnect to Google Fonts), image dimension attributes on all cards, reduce layout shift in accordion components.

Expand search to cover glossary terms, conditions, insights articles, and researchers. Add search result type filters. Implement SearchAction schema update to reflect expanded scope.

Add an RSS 2.0 feed at /insights/feed.xml for the Insights section. Enables syndication to research aggregators, Feedly, and academic RSS readers.

Establish a named medical review board of 3–5 clinicians who review content. Display reviewer credentials on each reviewed page. Add MedicalOrganization schema for the board.

Add visible "Reviewed by [Name, Credentials]" badges to topic hubs, compound pages, and condition pages — with review date and next review date. Link to reviewer profile.

Every factual claim on topic/compound/condition pages should have an inline citation number linking to the study detail page or external DOI. Currently citations are listed at page bottom without inline anchoring.

Display a "Last reviewed: [date]" timestamp on every topic hub, compound page, and condition page — with a commitment to annual review cycles. Update dateModified in JSON-LD dynamically.

Add a clear COI disclosure policy to the editorial standards page and a brief disclosure statement on each page noting that MarijuanaResearch.com has no financial ties to cannabis industry.

Monthly "Cannabis Research Digest" email: 3 new studies summarized, 1 Q&A spotlight, 1 researcher profile, and policy updates. Signup with email backend and double opt-in.

Curated feed of recent cannabis research news — new study publications, FDA decisions, policy changes, and conference highlights. Updated weekly. Distinct from the Insights long-form section.

Dedicated landing page for healthcare providers: CME resources, prescribing guidelines by jurisdiction, patient handout templates, and a directory of cannabis-knowledgeable clinicians by specialty.

Add share buttons to study pages, Q&A entries, and Insights articles. Pre-populate share text with key finding + URL. Add "Copy citation" button to study pages for academic sharing.

Expand the /press page with: downloadable media kit (PDF), high-res logo files, key statistics about the site, expert contact form, and a "data available for licensing" section.